Silo Pharma Inc SILO

Healthcare Psychedelics

Silo Pharma, Inc. is a developmental stage biopharmaceutical company. The Company is focused on developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It is engaged in acquiring and/or developing intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the potential benefits they may have in certain cases involving depression, mental health issues and neurological disorders. The Company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. Its SP-26 is a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. Its two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS).

NDAQ:SILO - Post by User

Silo Pharma Inc

Bullboard Posts

Next >>

Post by Alexandchoyon Mar 15, 2021 4:54pm

154 Views

Post# 32801230

SILO looking awesome

SILO is one of the only companies in the world offering psychedelic retreats in Jamaica and now announcing deal with Marley family to make Bob Marley branded psychedelic products. Down to $0.30 and still one of the most undervalued #psychedelic companies rn with only $18M mc

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season